More recently, THZ1 was shown to inhibit the growth of triple-negative breast cancer (TNBC) and ER+ BC) cells by inhibiting phosphorylation of the RNA Pol II CTD [20] and Ser118 of the ER [21, 22], respectively. Here, ESR1 is linked to breast cancer.